365 related articles for article (PubMed ID: 21683627)
21. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis.
Summers SA; Steinmetz OM; Gan PY; Ooi JD; Odobasic D; Kitching AR; Holdsworth SR
Arthritis Rheum; 2011 Apr; 63(4):1124-35. PubMed ID: 21190299
[TBL] [Abstract][Full Text] [Related]
23. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
24. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
25. UNC93B1 variants underlie TLR7-dependent autoimmunity.
Wolf C; Lim EL; Mokhtari M; Kind B; Odainic A; Lara-Villacanas E; Koss S; Mages S; Menzel K; Engel K; Dückers G; Bernbeck B; Schneider DT; Siepermann K; Niehues T; Goetzke CC; Durek P; Minden K; Dörner T; Stittrich A; Szelinski F; Guerra GM; Massoud M; Bieringer M; de Oliveira Mann CC; Beltrán E; Kallinich T; Mashreghi MF; Schmidt SV; Latz E; Klughammer J; Majer O; Lee-Kirsch MA
Sci Immunol; 2024 Feb; 9(92):eadi9769. PubMed ID: 38207055
[TBL] [Abstract][Full Text] [Related]
26. Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi.
Caetano BC; Carmo BB; Melo MB; Cerny A; dos Santos SL; Bartholomeu DC; Golenbock DT; Gazzinelli RT
J Immunol; 2011 Aug; 187(4):1903-11. PubMed ID: 21753151
[TBL] [Abstract][Full Text] [Related]
27. Guanosine and its modified derivatives are endogenous ligands for TLR7.
Shibata T; Ohto U; Nomura S; Kibata K; Motoi Y; Zhang Y; Murakami Y; Fukui R; Ishimoto T; Sano S; Ito T; Shimizu T; Miyake K
Int Immunol; 2016 May; 28(5):211-22. PubMed ID: 26489884
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 7 mediates early innate immune responses to malaria.
Baccarella A; Fontana MF; Chen EC; Kim CC
Infect Immun; 2013 Dec; 81(12):4431-42. PubMed ID: 24042114
[TBL] [Abstract][Full Text] [Related]
29. A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding.
Iavarone C; Ramsauer K; Kubarenko AV; Debasitis JC; Leykin I; Weber AN; Siggs OM; Beutler B; Zhang P; Otten G; D'Oro U; Valiante NM; Mbow ML; Visintin A
J Immunol; 2011 Apr; 186(7):4213-22. PubMed ID: 21383246
[TBL] [Abstract][Full Text] [Related]
30. TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy.
Ye J; Wang Y; Liu X; Li L; Opejin A; Hsueh EC; Luo H; Wang T; Hawiger D; Peng G
J Immunol; 2017 Aug; 199(3):941-954. PubMed ID: 28652396
[TBL] [Abstract][Full Text] [Related]
31. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
32. TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells.
Lalive PH; Benkhoucha M; Tran NL; Kreutzfeldt M; Merkler D; Santiago-Raber ML
Eur J Immunol; 2014 Jan; 44(1):46-57. PubMed ID: 24018482
[TBL] [Abstract][Full Text] [Related]
33. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.
Jackson SW; Scharping NE; Kolhatkar NS; Khim S; Schwartz MA; Li QZ; Hudkins KL; Alpers CE; Liggitt D; Rawlings DJ
J Immunol; 2014 May; 192(10):4525-32. PubMed ID: 24711620
[TBL] [Abstract][Full Text] [Related]
34. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling.
Brinkmann MM; Spooner E; Hoebe K; Beutler B; Ploegh HL; Kim YM
J Cell Biol; 2007 Apr; 177(2):265-75. PubMed ID: 17452530
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases.
Inoue N; Katsumata Y; Watanabe M; Ishido N; Manabe Y; Watanabe A; Masutani R; Hidaka Y; Iwatani Y
Autoimmunity; 2017 May; 50(3):182-191. PubMed ID: 28013570
[TBL] [Abstract][Full Text] [Related]
36. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
Haas T; Metzger J; Schmitz F; Heit A; Müller T; Latz E; Wagner H
Immunity; 2008 Mar; 28(3):315-23. PubMed ID: 18342006
[TBL] [Abstract][Full Text] [Related]
37. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.
Ewald SE; Lee BL; Lau L; Wickliffe KE; Shi GP; Chapman HA; Barton GM
Nature; 2008 Dec; 456(7222):658-62. PubMed ID: 18820679
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of the endoplasmic reticulum transmembrane protein UNC93B in the B cells of patients with active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki S; Watanabe T; Amano H; Takasaki Y
Rheumatology (Oxford); 2010 May; 49(5):876-81. PubMed ID: 20159909
[TBL] [Abstract][Full Text] [Related]
40. Necrotizing lymphadenitis may be induced by overexpression of Toll-like receptor7 (TLR7) caused by reduced TLR9 transport in plasmacytoid dendritic cells (PDCs).
Asano S; Sato H; Mori K; Yamazaki K; Naito H; Suzuki H
J Clin Exp Hematop; 2021 Jun; 61(2):85-92. PubMed ID: 33994431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
